GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.

Guizhou Xinbang Pharmaceutical Co., Ltd.

002390

CNE100000NG5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 14/07/2024 BST			5-day change	1st Jan Change
3.35 ^CNY	-0.89%		+0.60%	-24.55%

07-09	Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	CI
07-08	Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 14, 2023, has closed with 45,659,040 shares, representing 2.37% for CNY 196.2 million.	CI

Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.

July 09, 2024 at 05:00 pm

From July 1, 2024 to July 8, 2024, the company has repurchased 1,786,500 shares, representing 0.09% for CNY 3.71 million. With this, the company has completed the repurchase of 47,445,540 shares, representing 2.47% for CNY 199.91 million under the buyback announced on July 14, 2023.

Latest news about Guizhou Xinbang Pharmaceutical Co., Ltd.

Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	07-09	CI
Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 14, 2023, has closed with 45,659,040 shares, representing 2.37% for CNY 196.2 million.	07-07	CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	07-03	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2023, Payable on 17 May 2024	05-13	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023	05-08	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-28	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-15	CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	04-01	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Board Appointments	02-21	CI
Xinbang Pharma Chairman Buys 14 Million Yuan More Shares	01-04	MT
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	01-03	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23	CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	09/10/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. commences an Equity Buyback Plan for 14,705,882 shares, representing 0.76% for CNY 200 million, under the authorization approved on July 13, 2023.	14/07/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	26/06/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component Index	09/06/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component A Share Index	09/06/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 30 May 2023	24/05/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Final Dividend for 2022	15/05/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022	18/04/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	17/04/23	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22	CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI

Chart Guizhou Xinbang Pharmaceutical Co., Ltd.

Duration

Period

Chart Guizhou Xinbang Pharmaceutical Co., Ltd.

More charts

Company Profile

GUIZHOU XINBANG PHARMACEUTICAL Co., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of medical products. The Company operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment includes rapid wholesale business and medicine retail business. The Medical Services segment is engaged in the provision of medical services. It operates its businesses primarily in domestic markets.

Sector

Pharmaceuticals

Calendar

30/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.	-24.55%	889M
DONG-E-E-JIAO CO.,LTD.	+13.97%	4.95B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-32.08%	3.6B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-1.63%	3.03B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.62%	2.66B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-9.82%	2.34B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+38.87%	1.85B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+38.84%	1.45B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.47%	1.41B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.38B

Alternative Medicine

Guizhou Xinbang Pharmaceutical Co., Ltd.

Equities

002390

CNE100000NG5

Pharmaceuticals

Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.

Latest news about Guizhou Xinbang Pharmaceutical Co., Ltd.

Chart Guizhou Xinbang Pharmaceutical Co., Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Alternative Medicine